The benefits of institutional structured investments

STRUCTURED PRODUCTS

clock • 6 min read

Ed Senior, manager of the Atlantic House Structured Products fund, explains how institutional structured investments' risk premiums can be monetised.

Mention the word ‘derivative’, or specifically ‘option’, and it is a 50:50 bet as to whether the person opposite you nods knowingly, or winces and asks you to change the topic. However, there is no getting away from the fact the derivatives market is a significant one, with traded volumes around the world extending to £875bn, daily (see chart below). Derivatives, whether being used as investment vehicles, or for hedging purposes, span pretty much every industry sector. Be it an insurance company or pension fund hedging its long-term interest rates liabilities, a large industrial corpo...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
European private equity yet to spend €270bn worth of capital

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Early-stage biopharma: An opportunity for strategic investment

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot